Tefé-Silva, C., Rodrigues, B. G., Pascoal, B. B., Minante, B. I., Vitoreli, B. C., de Sousa, B., arros, I. S. B., Fortunato, I. M., & de Castro, S. C. (2023). TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA. Journal of Applied Pharmaceutical Sciences and Research, 5(4), 1-6. https://doi.org/10.31069/japsr.v5i4.01